La Brosse Nicole Insider Trades

Insider Trading History

Track insider trading activity for La Brosse Nicole. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.54M 36,357 shares
Last Trade
Feb 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$472k 6,688 shares
$70.64
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.94M 42,102 shares
Last Trade
Feb 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$472k 6,688 shares
$70.64
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.69M 38,494 shares
Last Trade
Feb 23, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$255k 3,608 shares
$70.64
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.67M 38,290 shares
Last Trade
Feb 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$378k 5,332 shares
$70.98
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.47M 35,414 shares
Last Trade
Feb 20, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$204k 2,876 shares
$70.98
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.12M 15,995 shares
Last Trade
Feb 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$378k 5,332 shares
$70.98
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $372k 5,329 shares
Last Trade
Feb 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$423k 5,329 shares
$79.44
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Feb 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$405k 5,093 shares
$79.44
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Feb 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.06M 13,351 shares
$79.44
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.81M 40,231 shares
Last Trade
Feb 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.06M 13,351 shares
$79.44
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.3M 32,958 shares
Last Trade
Feb 16, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$578k 7,273 shares
$79.44
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.08M 29,754 shares
Last Trade
Feb 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$423k 5,329 shares
$79.44
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.9M 27,172 shares
Last Trade
Feb 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$405k 5,093 shares
$79.44
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.88M 26,880 shares
Last Trade
Feb 16, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$228k 2,874 shares
$79.44
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.71M 24,425 shares
Last Trade
Feb 16, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$218k 2,747 shares
$79.44
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $3.01M 43,045 shares
Last Trade
Feb 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 7,448 shares
$80.48
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.06M 29,502 shares
Last Trade
Feb 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.37M 29,502 shares
$80.48
$69.82
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $932k 13,351 shares
Last Trade
Feb 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$416k 5,167 shares
$80.48
$69.82

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up